Investors, Brace Yourselves for More Drug-Price Drama

The next leg of the Trump administration’s plan to lower the cost of drug prices could get ugly for investors.

As soon as Thursday the Food and Drug Administration plans to publish a database of complaint letters from generic drug companies to the agency alleging anticompetitive activities from branded pharmaceutical companies. It is likely that some complaints will pertain to high-price blockbuster drugs that investors watch most closely.

... Nguồn: www.wsj.com